BE505709A - - Google Patents

Info

Publication number

BE505709A

BE505709A BE505709DA BE505709A BE 505709 A BE505709 A BE 505709A BE 505709D A BE505709D A BE 505709DA BE 505709 A BE505709 A BE 505709A

Authority

BE

Belgium

Prior art keywords

sep

penicillin

terramycin

antibiotic

salmonella

Prior art date

Links

• Espacenet
• Global Dossier
• Discuss

• 230000003115 biocidal Effects 0.000 claims description 40
• 239000000203 mixture Substances 0.000 claims description 32
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 30
• 229940049954 Penicillin Drugs 0.000 claims description 22
• 229960000626 benzylpenicillin Drugs 0.000 claims description 22
• 239000003242 anti bacterial agent Substances 0.000 claims description 18
• IWVCMVBTMGNXQD-PXOLEDIWSA-N Oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 claims description 16
• 229960000625 Oxytetracycline Drugs 0.000 claims description 13
• 229940063650 Terramycin Drugs 0.000 claims description 13
• 229940056360 Penicillin G Drugs 0.000 claims description 9
• SVDOODSCHVSYEK-IFLJXUKPSA-N (4S,4aR,5S,5aR,6S,12aR)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydron;chloride Chemical compound Cl.C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O SVDOODSCHVSYEK-IFLJXUKPSA-N 0.000 claims description 8
• 239000011780 sodium chloride Substances 0.000 claims description 5
• KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 3
• 229910052708 sodium Inorganic materials 0.000 claims description 3
• 239000011734 sodium Substances 0.000 claims description 3
• -1 penicillin salt Chemical class 0.000 claims description 2
• 239000000126 substance Substances 0.000 claims description 2
• 230000000875 corresponding Effects 0.000 claims 2
• FCPVYOBCFFNJFS-LQDWTQKMSA-M benzylpenicillin sodium Chemical compound [Na+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 FCPVYOBCFFNJFS-LQDWTQKMSA-M 0.000 claims 1
• 229920001098 polystyrene-block-poly(ethylene/propylene) Polymers 0.000 description 73
• 244000005700 microbiome Species 0.000 description 19
• 206010039447 Salmonellosis Diseases 0.000 description 14
• 229940064005 Antibiotic throat preparations Drugs 0.000 description 13
• 229940083879 Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Drugs 0.000 description 13
• 229940042052 Antibiotics for systemic use Drugs 0.000 description 13
• 229940042786 Antitubercular Antibiotics Drugs 0.000 description 13
• 229940093922 Gynecological Antibiotics Drugs 0.000 description 13
• 241000607142 Salmonella Species 0.000 description 13
• 229940024982 Topical Antifungal Antibiotics Drugs 0.000 description 13
• 229940079866 intestinal antibiotics Drugs 0.000 description 13
• 229940005935 ophthalmologic Antibiotics Drugs 0.000 description 13
• 230000000694 effects Effects 0.000 description 8
• 241000894006 Bacteria Species 0.000 description 6
• 201000009910 diseases by infectious agent Diseases 0.000 description 6
• 241000589516 Pseudomonas Species 0.000 description 4
• 239000003814 drug Substances 0.000 description 4
• 230000002401 inhibitory effect Effects 0.000 description 4
• 239000002253 acid Substances 0.000 description 3
• 150000007513 acids Chemical class 0.000 description 3
• 239000003795 chemical substances by application Substances 0.000 description 3
• 150000001875 compounds Chemical class 0.000 description 3
• 201000010099 disease Diseases 0.000 description 3
• 230000002458 infectious Effects 0.000 description 3
• 150000003839 salts Chemical class 0.000 description 3
• 241000282414 Homo sapiens Species 0.000 description 2
• 239000004599 antimicrobial Substances 0.000 description 2
• 230000001580 bacterial Effects 0.000 description 2
• 239000007853 buffer solution Substances 0.000 description 2
• 239000002054 inoculum Substances 0.000 description 2
• 239000000463 material Substances 0.000 description 2
• 230000003000 nontoxic Effects 0.000 description 2
• 231100000252 nontoxic Toxicity 0.000 description 2
• 235000015097 nutrients Nutrition 0.000 description 2
• 244000144977 poultry Species 0.000 description 2
• 239000000243 solution Substances 0.000 description 2
• 241000894007 species Species 0.000 description 2
• 238000001228 spectrum Methods 0.000 description 2
• 230000001225 therapeutic Effects 0.000 description 2
• 238000002560 therapeutic procedure Methods 0.000 description 2
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
• ACAZKHULUUVWCY-JFGNBEQYSA-N (2S,5R,6R)-6-(hexanoylamino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Chemical compound S1C(C)(C)[C@H](C(O)=O)N2C(=O)[C@@H](NC(=O)CCCCC)[C@H]21 ACAZKHULUUVWCY-JFGNBEQYSA-N 0.000 description 1
• SVDOODSCHVSYEK-UHFFFAOYSA-N 4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride Chemical compound Cl.C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(=O)C(C(N)=O)=C(O)C4(O)C(=O)C3=C(O)C2=C1O SVDOODSCHVSYEK-UHFFFAOYSA-N 0.000 description 1
• 206010000210 Abortion Diseases 0.000 description 1
• 208000010227 Enterocolitis Diseases 0.000 description 1
• VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
• 241000282412 Homo Species 0.000 description 1
• 241001465754 Metazoa Species 0.000 description 1
• 206010031252 Osteomyelitis Diseases 0.000 description 1
• 206010033971 Paratyphoid fever Diseases 0.000 description 1
• QRLCJUNAKLMRGP-ZTWGYATJSA-N Penicillin F Chemical compound S1C(C)(C)[C@H](C(O)=O)N2C(=O)[C@@H](NC(=O)C/C=C/CC)[C@H]21 QRLCJUNAKLMRGP-ZTWGYATJSA-N 0.000 description 1
• XVASOOUVMJAZNJ-MBNYWOFBSA-N Penicillin K Chemical compound S1C(C)(C)[C@H](C(O)=O)N2C(=O)[C@@H](NC(=O)CCCCCCC)[C@H]21 XVASOOUVMJAZNJ-MBNYWOFBSA-N 0.000 description 1
• 241000228150 Penicillium chrysogenum Species 0.000 description 1
• 206010035664 Pneumonia Diseases 0.000 description 1
• 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
• 229940055023 Pseudomonas aeruginosa Drugs 0.000 description 1
• 206010039438 Salmonella infection Diseases 0.000 description 1
• 206010040047 Sepsis Diseases 0.000 description 1
• 210000002784 Stomach Anatomy 0.000 description 1
• 241000187419 Streptomyces rimosus Species 0.000 description 1
• 231100000176 abortion Toxicity 0.000 description 1
• 229910052783 alkali metal Inorganic materials 0.000 description 1
• 230000000845 anti-microbial Effects 0.000 description 1
• 239000002246 antineoplastic agent Substances 0.000 description 1
• UIIMBOGNXHQVGW-UHFFFAOYSA-M buffer Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
• 159000000007 calcium salts Chemical class 0.000 description 1
• 239000002775 capsule Substances 0.000 description 1
• 238000004040 coloring Methods 0.000 description 1
• 230000018109 developmental process Effects 0.000 description 1
• 229940079593 drugs Drugs 0.000 description 1
• 235000013601 eggs Nutrition 0.000 description 1
• 230000001747 exhibiting Effects 0.000 description 1
• 235000013305 food Nutrition 0.000 description 1
• 235000013905 glycine and its sodium salt Nutrition 0.000 description 1
• 239000004247 glycine and its sodium salt Substances 0.000 description 1
• 239000001056 green pigment Substances 0.000 description 1
• 150000004677 hydrates Chemical class 0.000 description 1
• 238000002347 injection Methods 0.000 description 1
• 239000007924 injection Substances 0.000 description 1
• 229910052500 inorganic mineral Inorganic materials 0.000 description 1
• 230000000968 intestinal Effects 0.000 description 1
• 239000007788 liquid Substances 0.000 description 1
• 230000000813 microbial Effects 0.000 description 1
• 239000011707 mineral Substances 0.000 description 1
• 230000003287 optical Effects 0.000 description 1
• 235000015277 pork Nutrition 0.000 description 1
• 230000002980 postoperative Effects 0.000 description 1
• 159000000001 potassium salts Chemical class 0.000 description 1
• 230000035945 sensitivity Effects 0.000 description 1
• 229940029258 sodium glycinate Drugs 0.000 description 1
• 159000000000 sodium salts Chemical class 0.000 description 1
• WUWHFEHKUQVYLF-UHFFFAOYSA-M sodium;2-aminoacetate Chemical compound [Na+].NCC([O-])=O WUWHFEHKUQVYLF-UHFFFAOYSA-M 0.000 description 1
• 239000002689 soil Substances 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 230000002195 synergetic Effects 0.000 description 1
• 200000000019 wound Diseases 0.000 description 1

Cited By (4)